南财智讯3月15日电，金斯瑞生物科技（01548.HK）公告，截至2025年12月31日止年度，公司总收益为9.60亿美元，同比增长61.4%；年内亏损为5.32亿美元；每股基本亏损为0.25美元。
（文章来源：南方财经网）
南财智讯3月15日电，金斯瑞生物科技（01548.HK）公告，截至2025年12月31日止年度，公司总收益为9.60亿美元，同比增长61.4%；年内亏损为5.32亿美元；每股基本亏损为0.25美元。
（文章来源：南方财经网）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.